NIAAA: Current and Future Priorities. George F. Koob, Ph.D. Director National Institute on Alcohol Abuse and Alcoholism National Institutes of Health
|
|
- Paula Holt
- 5 years ago
- Views:
Transcription
1 NIAAA: Current and Future Priorities George F. Koob, Ph.D. Director National Institute on Alcohol Abuse and Alcoholism National Institutes of Health
2 Cost and Scope of Addiction
3 Alcohol Issues Across the Lifespan NIAAA supports research to study how alcohol can affect health and well-being at various stages of life. Alcohol Lifespan Transcending Themes Neurobiology Metabolism Genetics Epigenetics Epidemiology Health Services Research Alcoholic Family Environment Alcohol Dependence Medication Interactions Prenatal Alcohol Exposure Binge Drinking Organ Damage
4 Special Thanks to Dr. Ken Warren Acting Director NIAAA Deputy Director NIAAA Czar of Fetal Alcohol Syndrome Portfolio
5 NIAAA Extramural Grant Portfolio, FY 2013 Total Funding $319,759,079 n=955 (sequestration) Neuroscience & Behavior (n=403) $123,522,551 Health Services (n=32) $15,428,018 $42,571,054 $31,428,670 Treatment (n=102) $32,443,946 Prevention (n=84) Metabolism & Health Effects (n=239) $74,364,840 Epidemiology (n=95) NIAAA Trans-Divisional Research Emphasis Areas Biomarkers Fetal Alcohol Spectrum Disorders Genes and Environment Health Disparities HIV and AIDS Systems Biology Medications Development International Research Mechanisms of Behavior Change Underage Drinking
6 Current NIAAA Priority Programs 1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders 2. Underage and College Drinking 3. Neurobiology of Alcoholism 4. Genetics of Alcoholism 5. Treatment of Alcoholism 6.. Alcoholic Liver Disease 7. HIV/AIDS
7 Current NIAAA Priority Programs 1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders 2. Underage and College Drinking 3. Neurobiology of Alcoholism 4. Genetics of Alcoholism 5. Treatment of Alcoholism 6.. Alcoholic Liver Disease 7. HIV/AIDS
8 FASD Research Research Challenges: Improve diagnostic capabilities to determine the full prevalence of Fetal Alcohol Spectrum Disorder (FASD) and identify women and children in need of care and services Improve detection of risk drinking during pregnancy by developing new biomarkers Given the subtlety of FAS facial deficits improve the acumen for FAS facial recognition through 3-D photography and computer analysis Refine our understanding of the complexities in the neurobehavioral phenotype associated with FASD Prevent and/or ameliorate the effects of FASD through nutritional supplementations, pharmacology, or enhanced CNS stimulation
9 FASD Consortia Collaborative Initiative on Fetal Alcohol Spectrum Disorders (FASD) ongoing since 2003 : Consortium of approximately 8 Principal Investigators and many Coinvestigators Animal and human research International project with study sites in U.S., South Africa, Europe, Asia Research from CIFASD was critical to acceptance by APA of a new diagnostic category for Neurobehavioral Disorder: Prenatal Alcohol Exposed Prenatal Alcohol, Sudden Infant Death Syndrome (SIDS)), and Stillbirth (PASS) Joint initiative with NICHD and Deafness Institute On-going since 2003 Study sites in: South and North Dakota population Caucasian and American Indian South Africa mixed ancestry population known as Cape Coloured Major dependent variable is alcohol, secondary tobacco and other drugs (e.g., methamphetamine); study is powered on rarest outcome, i.e., SIDS
10 Current NIAAA Priority Programs 1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders 2. Underage and College Drinking 3. Neurobiology of Alcoholism 4. Genetics of Alcoholism 5. Treatment of Alcoholism 6.. Alcoholic Liver Disease 7. HIV/AIDS
11 Neurobiology of Adolescent Drinking in Adulthood (NADIA) Animal Studies Complementing N-CANDA, NADIA uses animal models to assess the effects of adolescent alcohol exposure on the adult brain. Unlike studies with human adolescents, animal studies can control environmental factors and administer alcohol during adolescence.
12 Objectives: National Consortium on Alcohol and Neurodevelopment in Adolescence Study effects of alcohol exposure on trajectory of adolescent brain development in the context of development Examine dose, duration, and timing effects of alcohol exposure Determine what structural and functional anomalies are the result of alcohol exposure and what predates, and may predict, heavy alcohol use Identify neuroimaging and/or neurocognitive brain markers that predict onset of AUD and other psychopathology
13 OHSU Portland Dolf Pfefferbaum Torsten Rohlfing Bonnie Nagel Robert Zucker (SAB) Raquel Gur (SAB) Duncan Clark SRI/Stanford PiLsburgh Ian Colrain Fiona Baker UC San Diego Susan Tapert Sandra Brown Ken Sher (SAB) Sites Advisors Collabora0ons Andrea Hussong (SAB) Duke Mike DeBellis Supporte d by: NIAAA NIMH NICHD NIDA
14 College Drinking College Drinking Intervention Matrix Coming Soon In response to a request from NIAAA s College Presidents Working Group, NIAAA engaged top researchers in the field to develop an interactive, user-friendly, print and online decision support system to help colleges and universities select appropriate strategies to meet their alcohol intervention goals. The tool will allow college presidents and staff to review the strategies they are already using as well as explore others that may serve them better. Users will be able to search for strategies according to intervention level (e.g., individual, group, campus-wide, community) and evaluate other factors, such as effectiveness, barriers and costs, affecting implementation We envision that much like online shopping applications, the online tool will allow users to select a set of strategies for side-by-side comparisons
15 Current NIAAA Priority Programs 1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders 2. Underage and College Drinking 3. Neurobiology of Alcoholism 4. Genetics of Alcoholism 5. Treatment of Alcoholism 6.. Alcoholic Liver Disease 7. HIV/AIDS
16 Conceptual Framework for Neurobiological Bases of the Transition to Excessive Drinking
17 Integrative Neuroscience Initiative on Alcoholism (INIA) NeuroadaptaQon An 11 site multidisciplinary consortium devoted to identifying molecular, cellular, and behavioral neuroadaptations that occur in the brain due to alcohol exposure that contribute to excessive alcohol consumption in some individuals. The current objective of INIA is to confirm previously identified gene targets and identify druggable targets that are the most promising for medications development for the treatment of alcoholism. This will be achieved using: the extensive INIA genomics data set the INIA mutant mouse and behavioral testing cores INIA electrophysiology expertise
18 Integrative Neuroscience Initiative on Alcoholism (INIA) INIA- Stress A cooperative consortium of 15 Principal Investigators from 9 academic institutions across the US. The INIA stress consortium uses a state-of-the art translational approach (mice, monkeys and humans) to: Ø understand the interaction of genetic variation and stress on the promotion of excessive drinking Ø identify novel, effective and tailored treatment strategies for alcoholism.
19 Collaborative Study on the Genetics of Alcoholism (COGA) Primary Goal of COGA: To find and understand genes that affect the risk for the development of alcoholism and related disorders. This is being accomplished through linkage, GWAS, and whole-exome sequencing studies as well as gene expression and epigenetic studies. The COGA family pedigrees are densely affected with alcoholism containing at least 2 alcohol-dependent first-degree relatives in addition to an alcohol dependent proband. Participants from 9 US sites
20 Current NIAAA Priority Programs 1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders 2. Underage and College Drinking 3. Neurobiology of Alcoholism 4. Genetics of Alcoholism 5. Treatment of Alcoholism 6. Alcoholic Liver Disease 7. HIV/AIDS
21 NIAAA Medications Development Program for Alcohol Use Disorder (AUD), High-Risk Drinking, and Alcohol-Related Medical Disorders Mission: To improve the care and treatment of those affected by AUD, high-risk drinking, and alcohol-related medical disorders by supporting the development of effective and safe medications that are accepted and used by clinicians and patients. Overall Goal: Translate promising medications from discovery to preclinical and human clinical testing to realworld effectiveness and implementation studies.
22 SCREENING MODELS VALIDATION PROCESS: BIDIRECTIONAL INTEGRATION Molecular Targets Animal Models Human Laboratory Models Clinical Trials
23 NIAAA Clinical Investigation Group PURPOSE (NCIG) Network of Sites for Proof of Concept Trials Bridge gap between preclinical studies and expensive, time-consuming Phase 3 trial Quick turnaround (1½ years) Access to many CNS compounds of pharmaceutical companies Ability to deal with intellectual property Study design flexibility
24 Current NIAAA Priority Programs 1. Fetal Alcohol Syndrome/ Fetal Alcohol Spectrum Disorders 2. Underage and College Drinking 3. Neurobiology of Alcoholism 4. Genetics of Alcoholism 5. Treatment of Alcoholism 6.. Alcoholic Liver Disease 7. HIV/AIDS
25 Building a New Research Program for Alcoholic Hepatitis Create a rich and fertile environment for new and collaborations Understand the pathogenesis and identify new molecular targets Identify best therapeutic regiments based on patients risk factors, pathogenesis, prognosis
26 Veterans Aging Cohort Study (VACS) The Veterans Aging Cohort Study (VACS) is a prospective, observational cohort study of HIVpositive and an age/race/site matched control group of HIV- negative veterans in care in the United States. The study's aim is to understand the role of comorbid medical and psychiatric disease in determining clinical outcomes in HIV infection. The study has a special focus on the role of alcohol use and abuse in determining clinical outcomes.
27 Future NIAAA Priority Programs 1. Functional Merge: Co-morbidity, Co- training, Co- Prevention, Co- Treatment 2. Neurobiology of Intoxication 3. Sleep and Alcoholism 4. Post traumatic Stress Disorder 5. Standardization of Prevention Options for Middle and Secondary Schools 5. Standardization of Prevention Options for College Campuses
28 Collaborative Research on Addiction at NIH (CRAN)
29 Uber CRAN? National Longitudinal Study of Neurodevelopmental Consequences of Substance Use Study Aims: What is the impact of the sporadic versus the regular use of marijuana, alcohol, nicotine and other substances on the developing brain? What are the neurodevelopmental pathways that link adolescent substance use and pre-existing or emerging mental illnesses? What are the effects of multiple substances in combination? Partnering Agencies: The study will be led by the Collaborative Research on Addiction (CRAN) at NIH (National Institute on Drug Abuse [NIDA], National Institute on Alcohol Abuse and Alcoholism [NIAAA], and the National Cancer Institute [NCI]) in collaboration with the National Institute of Child Health and Human Development (NICHD) and potentially other Institutes (National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Mental Health (NIMH)). We are also seeking partnership with other agencies (CDC, FDA, ONDCP) Study Design: The study will consist of a large representative cohort (i.e. approximately 10,000) youth that will be followed over a 10-year period, beginning before drug use is initiated and continuing into early adulthood.
30 Where we want to be 1. FDA approval for medications for treatment of alcoholism 2. Implementation of effective behavioral treatments for alcoholism 3. Implementation of effective prevention strategies for adolescent drinking 4. Implementation of effective prevention strategies for drinking during pregnancy 5. Elimination of alcohol related HIV pathology 6. Establishment of effective treatments for fetal alcohol spectrum disorder (FASD) 7. Development effective treatments for alcoholic liver disease 8. Appropriate treatment of co-morbidities associated with alcoholism 9. Successful recruitment of young investigators to the alcohol field, elimination of disparities in the alcohol field. Equal pay for women and minorities in the alcohol field
31 Thank You! George F. Koob, Ph.D. Director National Institute on Alcohol Abuse and Alcoholism National Institutes of Health
NIAAA: Current Priorities and Future Goals
NIAAA: Current Priorities and Future Goals George F. Koob, Ph.D. Director National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Alcool : quand l enfant trinque in utero (Alcohol:
More informationNIAAA: Current Priorities and Future Goals
NIAAA: Current Priorities and Future Goals George F. Koob, Ph.D. Director National Institute on Alcohol Abuse and Alcoholism National Institutes of Health Friends of NIAAA Annual Meeting May 12, 2015 Thank
More informationJoint NIAAA NIDA Council Meeting Kenneth R. Warren, Ph.D. Acting Director, NIAAA September 12, 2011
National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and Alcoholism Overview of NIAAA Programs Joint NIAAA NIDA Council Meeting Kenneth R. Warren, Ph.D. Acting Director,
More informationNIAAA: Researching Alcohol in America
NIAAA: Researching Alcohol in America Patricia Powell, Ph.D. Deputy Director National Institute on Alcohol Abuse and Alcoholism The NABCA Administrators Conference October 24, 2017 The National Institutes
More informationREPORT TO CONGRESS Multi-Disciplinary Brain Research and Data Sharing Efforts September 2013 The estimated cost of report or study for the Department of Defense is approximately $2,540 for the 2013 Fiscal
More informationAdvancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships
The National Academies of SCIENCES ENGINEERING MEDICINE Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships Leadership The NIH Pain Consortium Mission
More informationFogarty Initiatives for Building Capacity in HIV/AIDS
Fogarty Initiatives for Building Capacity in HIV/AIDS April 13, 2010 Michael P. Johnson, M.D., M.P.H Deputy Director Fogarty International Center Global Health Transition in 21 st Century the unfinished
More informationPlanning, Priority Setting, and Budget Development for NIH AIDS Research
Planning, Priority Setting, and Budget Development for NIH AIDS Research Robert W. Eisinger, Ph.D. Office of AIDS Research s of Health Focus of Presentation Overview of OAR Priority Setting Process Budget
More informationCollaborative Research on Addiction at NIH (CRAN) (Formerly known as Functional Integration)
Collaborative Research on Addiction at NIH (CRAN) (Formerly known as Functional Integration) National Institute on Drug Abuse Bringing the full power of science to bear on drug abuse and addiction Nora
More informationNIDA Director s Report to the National Advisory Councils of NIDA, NIAAA, & NCI February 4, Nora D. Volkow, M.D., Director
NIDA Director s Report to the National Advisory Councils of NIDA, NIAAA, & NCI February 4, 2015 Nora D. Volkow, M.D., Director $ (in thousands) NIDA Program Level in Appropriated Dollars and Constant 1998
More informationTobacco Research at NIDA: Neuroscience, Treatment and Regulatory-related studies
% of Basal Release Dopamine (nm) Wilson M. Compton, MD, MPE Deputy Director, National Institute on Drug Abuse Tobacco Research at NIDA: Neuroscience, Treatment and Regulatory-related studies Themes for
More informationSubmitted electronically to:
Submitted electronically to: ODOARRFI19@nih.gov Maureen Goodenow, PhD Associate Director of AIDS Research, NIH Director, Office of AIDS Research (OAR) National Institutes of Health 5601 Fishers Lane. Room
More informationOpportunities in Pain Research with the NIH HEAL Initiative
Opportunities in Pain Research with the NIH HEAL Initiative Clinton Wright, M.D. Director, Division of Clinical Research National Institute of Neurological Disorders and Stroke, NIH September 20, 2018
More informationNIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH
NIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH AAMC Webinar November 8, 2018 Walter J. Koroshetz, MD Director, National Institute of Neurological
More informationTuberous Sclerosis Complex Research Program
Tuberous Sclerosis Complex Research Program Strategic Plan INTRODUCTION The Congressionally Directed Medical Research Programs (CDMRP) represents a unique partnership among the U.S. Congress, the military,
More informationAutism: The Federal Effort. Thomas R. Insel, M.D. National Institute of Mental Health NIH/DHHS 12/16/05
Autism: The Federal Effort Thomas R. Insel, M.D. National Institute of Mental Health NIH/DHHS 12/16/05 The Inter-Agency Autism Coordinating Committee NIH (NIMH, NICHD, NINDS, NIEHS, NIDCD) CDC (Agency
More informationSociety for Prevention Research 2018 Call for Papers Author Abstract Submission Questions. Research Foci
Society for Prevention Research 2018 Call for Papers Author Abstract Submission Questions Research Foci Please select your Research Foci. (Select all that apply) Academic Achievement ADHD Addiction Aging
More informationThe National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations
The National Association of State Alcohol and Drug Abuse Directors (NASADAD) FY 2018 Appropriations March 2018 Update On March 23 rd, 2018, President Donald Trump signed a fiscal year 2018 (October 1,
More informationSafe Babies Foster Parent Training Program
Safe Babies Foster Parent Training Program Module 1: Introduction to the Safe Babies Program 1 Begin the process of group participation Learning outcomes Understand the purpose and origins of the Safe
More informationChronic Pain in Women and its Relationship to Opioid Addiction
Chronic Pain in Women and its Relationship to Opioid Addiction Advancing Addiction Science Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse OPIOIDS are Powerful Analgesics
More informationRunning Head: ALCOHOL AND PARENTAL IMPACT 1. Alcohol and Parental Impact
Running Head: ALCOHOL AND PARENTAL IMPACT 1 Alcohol and Parental Impact ALCOHOL AND PARENTAL IMPACT 2 Abstract The aim of this study is to identify the methods and findings on the research field of alcohol
More informationTBI Research at NIH. Ramona Hicks, PhD NIH/NINDS
TBI Research at NIH Ramona Hicks, PhD NIH/NINDS Objectives 1. Overview of TBI research opportunities at NIH 2. Highlight a few projects Common Data Element Project Federal Interagency TBI Research Informatics
More informationResearch Funding Opportunities at the National Institutes of Health
Research Funding Opportunities at the National Institutes of Health USAID MENA Research Partners Forum Amman, Jordan Marie D. Ricciardone, PhD Senior Advisor MENA Center for Global Health 16 March 2016
More informationScientific Discoveries Allow Development of Targeted Therapeutics for Individuals with Autism Spectrum Disorders
Scientific Discoveries Allow Development of Targeted Therapeutics for Individuals with Autism Spectrum Disorders Randall L. Carpenter, M.D. Co-Founder, President and CEO August 9, 2012 Research Supported
More informationAge & Sex Differences in Cognitive, Motor, & Sleep Indices: Initial Findings of the National Consortium on Alcohol & NeuroDevelopment in Adolescence
Research Society on Alcoholism San Antonio, TX 22 June 2015 Age & Sex Differences in Cognitive, Motor, & Sleep Indices: Initial Findings of the National Consortium on Alcohol & NeuroDevelopment in Adolescence
More informationUpdate on the Fetal Alcohol Spectrum Disorder Action Plan
Update on the Fetal Alcohol Spectrum Disorder Action Plan Thursday 17 March 2016 Addiction Treatment Leadership Day What this presentation covers FASD 101 The Action Plan (and feedback on it) Where to
More informationWHO International Collaborative Research Project on Child Development and Prenatal Risk Factors with a Focus on FASD. Dr V. Poznyak and Mr Dag Rekve
WHO International Collaborative Research Project on Child Development and Prenatal Risk Factors with a Focus on FASD Dr V. Poznyak and Mr Dag Rekve 1 Guiding principles of the Global strategy to reduce
More informationNIH Office of Research on Women s Health (ORWH)
NIH Office of Research on Women s Health (ORWH) Lisa Begg, Dr.P.H., RN Office of Research on Women's Health Office of the NIH Director National Institutes of Health Department of Health and Human Services
More informationNational Resources for Reducing Substance-Exposed Pregnancies
National Resources for Reducing Substance-Exposed Pregnancies SAMHSA FASD Center for Excellence 2101 Gaither Road, Suite 600 Rockville, MD 20850 http://fasdcenter.samhsa.gov Email: fasdcenter1@ngc.com
More informationJUST THE FACTS SUBSTANCE ABUSE IN INDIANA
JUST THE FACTS SUBSTANCE ABUSE IN INDIANA A quick summary on the use of alcohol, tobacco, marijuana, cocaine, heroin, methamphetamine, non-medical prescription drugs, and polysubstances in Indiana Prepared
More informationNIAAA s Medications Development Program to Treat Alcohol Use Disorder: Advances, Goals, and Initiatives
NIAAA s Medications Development Program to Treat Alcohol Use Disorder: Advances, Goals, and Initiatives Raye Z. Litten, Ph.D. Acting Director Division of Medications Development National Institute on Alcohol
More informationNeuroscience International Funding Opportunities at NINDS & NIH
Neuroscience International Funding Opportunities at NINDS & NIH Yuan Liu, PhD Chief, Office of International Activities of Neurological Disorders & Stroke (NINDS) s of Health (NIH) U.S.A. July 20, 2007
More informationNeurofibromatosis Research Program
Neurofibromatosis Research Program Strategic Plan INTRODUCTION The Congressionally Directed Medical Research Programs (CDMRP) represents a unique partnership among the U.S. Congress, the military, and
More informationthe Office of Research Application Portal: Materials to submit:
Title: PAR 17 237: Centers for AIDS Research (P30) Slots: 1 Internal Deadline: LOI: External Deadline: Award Information: Submission Process: May 26, 2018, 5pm PDT 30 days prior to the application due
More informationNeuropsychological Effects of Marijuana Use During Adolescence & Young Adulthood
Neuropsychological Effects of Marijuana Use During Adolescence & Young Adulthood Krista Lisdahl Medina, Ph.D., University of Cincinnati (Thank you: Susan Tapert, Ph.D., UCSD) Neuropsychological Effects
More informationTRANS-NIH PLAN FOR HIV RELATED RESEARCH
National Institutes of Health FY 2018 TRANS-NIH PLAN FOR HIV RELATED RESEARCH Prepared by the Office of AIDS Research Maureen M. Goodenow, Ph.D. NIH Associate Director for AIDS Research and Director, Office
More informationGovernment Bioscience Grant (GBG) Report April 2015
www.g2gconsulting.com www.michbio.org Government Bioscience Grant (GBG) Report April 2015 Title (Agency) Opp. Number Description Deadlin e Funding Level Eligibility Link KIDNEY 1 Pilot and Feasibility
More informationAn Analysis of NIMH HIV/AIDS Prevention Research Funding
THE AIDS INSTITUTE An Analysis of NIMH HIV/AIDS Prevention Research Funding Emily McCloskey, Public Policy Associate Carl Schmid, Deputy Executive Director United States Conference on AIDS Orlando, FL
More informationThe PhenX Toolkit: Standard Measures for Collaborative Research
The PhenX Toolkit: Standard Measures for Collaborative Research Clinical Common Data Elements Task Force (CDETF) November 4, 2016 Carol M. Hamilton, PhD RTI International is a trade name of Research Triangle
More informationUpdate from NIAAA. Alcohol Prevention, Treatment, and Recovery Research
Update from NIAAA Alcohol Prevention, Treatment, and Recovery Research Lori Ducharme, Ph.D. Program Director Division of Treatment & Recovery Research NASADAD 2017 Annual Meeting NIAAA Strategic Plan:
More informationFetal Alcohol Spectrum Disorders: Common but Under-Recognized in the U.S.
Fetal Alcohol Spectrum Disorders: Common but Under-Recognized in the U.S. Christina Chambers, PhD, MPH Co-Director of the Center for Better Beginnings Professor of Pediatrics Department of Pediatrics Department
More informationThe Essential Role of Growth Deficiency in the Diagnosis of FASD
The Essential Role of Growth Deficiency in the Diagnosis of FASD Susan Astley PhD Julia Bledsoe MD Julian Davies MD Members of the FAS DPN FASD Diagnostic Team University of Washington Seattle WA Published
More informationAn Update on the Interagency Autism Coordinating Committee (IACC) and the IACC Strategic Plan
An Update on the Interagency Autism Coordinating Committee (IACC) and the IACC Strategic Plan Autism CARES Grantee Meeting July 10, 2017 Susan A. Daniels, Ph.D. Director, Office of Autism Research Coordination
More informationAmerican Academy of Pediatrics 2014 Educational Webinar Series Monday, July 28, 3:00 3:30 pm ET
American Academy of Pediatrics 2014 Educational Webinar Series Monday, July 28, 3:00 3:30 pm ET FETAL ALCOHOL SPECTRUM DISORDERS (FASDS): DETECTION, DISCOVERY, AND DIAGNOSIS PRESENTED BY YASMIN SENTURIAS,
More informationBD-STEP: Tackling Key Issues Across Cancer Research and Care
BD-STEP: Tackling Key Issues Across Cancer Research and Care Michelle Berny-Lang, Ph.D. Program Director Center for Strategic Scientific Initiatives Office of the Director, National Cancer Institute BD-STEP
More informationSubstance Abuse in Indiana
February, 2010 For questions and additional information, please contact: Kim Manlove SPF SIG Project Director (317) 232-7887 Kim.Manlove@fssa.in.gov Larry Long SPF SIG Project Coordinator (317) 232-7931
More informationEffective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC.
Effective Strategies for Addressing the Needs of Substance Exposed Newborns & their Families Dixie L. Morgese, BA, CAP, ICADC Key Issues Significant increase in number of pregnant women addicted to prescription
More informationADNI Experience on Developing Biomarker Tools as Example of An Approach to Catalyzing Dry AMD Drug Development
ADNI Experience on Developing Biomarker Tools as Example of An Approach to Catalyzing Dry AMD Drug Development Wm Z Potter, MD, PhD Sr. Advisor, NIMH IOM, Nov 15, 2014 Disclosures Former employee of Lilly
More informationAdolescent Brain Development and Drug Abuse. Ken C. Winters, Ph.D. Professor, Department of Psychiatry, University of Minnesota
Adolescent Brain Development and Drug Abuse New findings indicate that brain development still in progress during adolescence; immature brain structures may place teenagers at elevated risk of substance
More informationThe NIH STTR Program
The NIH STTR Program May 1, 2015 Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator, NIH 1 Topics Size of NIH/HHS program Set-asides & spending Research Institutions and Universities in STTR Discretionary
More informationChallenging Community College Alcohol Use. Health Services Matthew Kiechle, MS, CHES, CPP
Challenging Community College Alcohol Use Health Services Matthew Kiechle, MS, CHES, CPP 1 Overview Identifying TC3 AOD rates, consequences Administrative charge Assembling Task Force TC3 challenges Evidence-based
More informationJohn Parrish-Sprowl Co-Director Global Health Communication Center IU School of Liberal Arts
John Parrish-Sprowl Co-Director Global Health Communication Center IU School of Liberal Arts My Background On the board of 5 nonprofit organizations and president of 2 Involved in various capacity building
More informationResearch Announcements for the Week Ending March 21, 2014
Research Announcements for the Week Ending March 21, 2014 Compiled by Julie C. Kong, MEd, RD, LN,CRA Director of Research Services, UIC School of Public Health 1. Aging 2. Cancer 3. Hepatitis C 4. International
More informationMaternal, Adolescent, and Pediatric HIV/AIDS Therapeutics Clinical Trials Network:
Maternal, Adolescent, and Pediatric HIV/AIDS Therapeutics Clinical Trials Network: Pregnant Women in the NIAID HIV/AIDS Clinical Trials Network Recompetition Carl W. Dieffenbach, Ph.D. Director Division
More informationTranslating Duke Health. Accelerating discovery and its translation
Translating Duke Health Accelerating discovery and its translation Translating Duke Health Biomedical discovery is accelerating innovative and revolutionary advancements in our understanding of human biology,
More informationFETAL ALCOHOL SPECTRUM DISORDERS (FASDs)
FETAL ALCOHOL SPECTRUM DISORDERS (FASDs) An Ounce of Prevention NC Child Fatality Task Force February 10 th, 2016 Amy Hendricks, Coordinator NC Fetal Alcohol Prevention Program FASDinNC.org Mission s Fullerton
More informationThe NIH SBIR/STTR Program & Universities
The NIH SBIR/STTR Program & Universities SBIR/STTR & Commercialization of University Innovations February 5, 2014 Matthew Portnoy, Ph.D. SBIR/STTR Program Coordinator, NIH 1 Topics Size of NIH/HHS program
More informationUse of Multimodal Neuroimaging Techniques to Examine Age, Sex, and Alcohol-Related Changes in Brain Structure Through Adolescence and Young Adulthood
American Psychiatric Association San Diego, CA 24 May 2017 Use of Multimodal Neuroimaging Techniques to Examine Age, Sex, and Alcohol-Related Changes in Brain Structure Through Adolescence and Young Adulthood
More informationThe Mystery of Risk. Drugs, Alcohol, Pregnancy and the Vulnerable Child. Ira J. Chasnoff, MD
The Mystery of Risk Drugs, Alcohol, Pregnancy and the Vulnerable Child Ira J. Chasnoff, MD irachasnoff@gmail.com Attachment: Basic Concepts n Attachment is the interconnectedness between human beings.
More informationAddiction and substance misuse
Addiction and substance misuse Research Strategy Addiction and substance misuse Research Strategy Contents Introduction 1 Overview 2 Rationale 2 Achievements 3 Timeline 4 Research supported through the
More informationLearning outcomes: Keeping it Real and Safe: What Every School Counselor Should Know About Underage Drinking
Keeping it Real and Safe: What Every School Counselor Should Know About Underage Drinking Aaron White, PhD - NIAAA April 18, 2018 Learning outcomes: Current trends in underage drinking How does alcohol
More informationAddiction Across the Lifespan
Addiction Across the Lifespan David Galbis-Reig, M.D., DFASAM Medical Director of Addiction Services Ascension Wisconsin All Saints OBJECTIVES Be able to explain how addiction interacts with psychosocial
More informationPhysical Therapist Practice and The Movement System
Physical Therapist Practice and The Movement System August 2015 An American Physical Therapy Association White Paper Physical Therapist Practice and the Movement System Introduction APTA s vision for the
More informationPeace Corps Global HIV/AIDS Strategy (FY )
The Peace corps :: global hiv/aids str ategy :: fisc al years 2009 2014 1 of 5 Peace Corps Global HIV/AIDS Strategy (FY 2009 2014) 2007 facts BacKGroUnd 33 million people are living with hiv. More than
More informationAdvancing Behavioral and Social Sciences Research to Meet the Challenges of Obesity and Diabetes
2012 Consortium of Social Science Associations (COSSA) Colloquium Advancing Behavioral and Social Sciences Research to Meet the Challenges of Obesity and Diabetes Griffin P. Rodgers, M.D., M.A.C.P. Director
More informationNCI Cancer Moonshot. Christine Siemon National Cancer Institute, NIH. November 30, 2017
NCI Cancer Moonshot Christine Siemon National Cancer Institute, NIH November 30, 2017 Presidential Memo 2016 Overall Goals of the Cancer Moonshot Accelerate progress in cancer, including prevention & screening
More informationThis is Your Brain after the Drugs: Neural Functioning in Adolescent Substance Users. Susan F. Tapert, Ph.D. University of California, San Diego
This is Your Brain after the Drugs: Neural Functioning in Adolescent Substance Users Susan F. Tapert, Ph.D. University of California, San Diego Overview What is normal adolescence? Does substance use affect
More informationThe Basics of FASD Awareness and Prevention Cheryl A. Wissick, Ph.D. Trainer, SC FASD Collaborative
The Basics of FASD Awareness and Prevention Cheryl A. Wissick, Ph.D. Trainer, SC FASD Collaborative Presentation adapted from information from Dan Dubovsky, FASD Specialist, FASD CFE, SAMHSA Roger Zoorob,
More informationParkinson s Research Program
Parkinson s Research Program Strategic Plan INTRODUCTION The Congressionally Directed Medical Research Programs (CDMRP) represents a unique partnership among the U.S. Congress, the military, and the public
More informationRequest for Applications Post-Traumatic Stress Disorder GWAS
Request for Applications Post-Traumatic Stress Disorder GWAS PROGRAM OVERVIEW Cohen Veterans Bioscience & The Stanley Center for Psychiatric Research at the Broad Institute Collaboration are supporting
More informationNational Institute on Drug Abuse Strategic Plan on Reducing Health Disparities
National Institute on Drug Abuse Strategic Plan on Reducing Health Disparities NIH Comprehensive Strategic Plan and Budget To Reduce and Ultimately Eliminate Health Disparities MISSION The mission of the
More informationDirector s Report to the National Advisory Council on Drug Abuse
Director s Report to the National Advisory Council on Drug Abuse May 15, 2018 Nora D. Volkow, M.D., Director National Institute on Drug Abuse @NIDAnews Office of Diversity & Health Disparities Office of
More informationSuccessful collaboration for research development between the NIH and patient organisations
Successful collaboration for research development between the NIH and patient organisations Stephen C. Groft, Pharm.D. Office of Rare Diseases s of Health Department of Health and Human Services EURORDIS
More informationEpilepsy Across the Spectrum Promoting Health and Understanding
RECOMMENDATIONS MARCH 2012 For more information visit www.iom.edu/epilepsy Epilepsy Across the Spectrum Promoting Health and Understanding Much can be done to improve the lives of people with epilepsy.
More informationTaking the Next Step: Innovative Interventions for Fetal Alcohol Spectrum Disorders (FASDs) A Description of Conference Proceedings
Taking the Next Step: Innovative Interventions for Fetal Alcohol Spectrum Disorders (FASDs) A Description of Conference Proceedings The second Marcus Autism Center Leadership Conference, entitled Taking
More informationLet s Talk PREVENTION
Let s Talk PREVENTION A Guide to Substance Use Prevention Education & Providers in This guide is published by The Suffolk County Partners in Prevention a Task Group of the Suffolk County Division of Community
More informationBJA Harold Rogers PDMP National Meeting on Data Driven Multi-Disciplinary Approaches to Reducing Rx Abuse
SAMHSA Programs to Address Prescription Drug Misuse and Abuse Jinhee Lee, PharmD Division of Pharmacologic Therapies Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration
More informationASD Research Opportunities
08 ASD Research Opportunities POTENTIAL ADDITIONAL RESEARCH OPPORTUNITY 243 244 ASD RESEARCH OPPORTUNITIES Intro Research around the country on ASD has focused on identifying autism genes, such as the
More informationResearch Priorities of NIDA s Medications Development Program
Research Priorities of NIDA s Medications Development Program Iván D. Montoya, M.D., M.P.H. Deputy Director, Division of Therapeutics and Medical Consequences NIDA No Disclosures NIDA Medications Development
More informationSAFEMINDS EVALUATION OF IACC BUDGET Green denotes SafeMinds Recommendations, Red denotes IACC future action. IACC Budget Recommendation 5,300,000
Green denotes SafeMinds s, Red denotes IACC future action 1. When Should I Be Concerned? ST 1.1 Develop, with existing tools, at least one efficient diagnostic instrument (e.g., briefer, less time intensive)
More informationLegend. Innovations in Treatment and Recovery. Industry Symposia Oral Communications E Short Communications SUNDAY FEBRUARY 25, 2018
Legend Plenary Innovations in Neuroscience Innovations in Treatment and Recovery Innovations in Thinking Innovations in Technologies Innovations in Policy and Planning Health Industry Symposia Oral Communications
More informationChronic Disease/Caregiver Management - Open Grant Opportunities
Chronic Disease/Caregiver Management - Open Grant Opportunities Sponsor Name of Program Deadline Brief Description Opportunity ID Rita Allen Foundation The Rita Allen Foundation and the American Pain Society's
More informationVirginia Student Services Conference Wintergreen, VA November, 2013
Virginia Student Services Conference Wintergreen, VA November, 2013 Presented By David S. Anderson, Ph.D. Professor George Mason University Linda Kirkland-Harris, M.Div., Ph.D., LPC Director, Student Counseling
More informationNational Center on Substance Abuse
National Center on Substance Abuse and Child Welfare Bringing Systems Together for Family Recovery, Safety and Stability September 24, 2009 Presented by: Cathleen Otero, MSW, MPA Deputy Director, NCSACW
More informationPSYCHIATRY. THE POWER OFx. Experts. Experience. Execution. A Deeper Dive into Psychiatry. Scientifically-Driven Clinical Development
THE POWER OFx Experts. Experience. Execution. A Deeper Dive into Psychiatry Incidences of mental disorders such as depression, bipolar, anxiety disorders, and schizophrenia continue to grow around the
More informationImproving data for cervical cancer programming
Improving data for cervical cancer programming Tools for supporting improved decision making Leanne Riley, WHO 102M Track 4 Rational The need A global absence of standardized tools and guidance, technical
More informationScience = Solutions. Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse
Advancing Addiction Science Science = Solutions Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse John Smith James Smith Ann
More informationTHE CANADA-ISRAEL TRANS-ATLANTIC COLLABORATION FOR BRAIN STUDIES
DISCUSSION PAPER THE CANADA-ISRAEL TRANS-ATLANTIC COLLABORATION FOR BRAIN STUDIES A Collaborative Research Partnership between Dalhousie University and Ben-Gurion University of the Negev WHERE BREAKTHROUGHS
More informationStrategic Plan for Science
Strategic Plan for Science 2018 2020 OVERVIEW Autism Speaks Mission Autism Speaks is dedicated to promoting solutions, across the spectrum and throughout the lifespan, to meet the needs of individuals
More informationFOSTERING THE NEXT GENERATION OF RESEARCHER IN HEALTH DISPARITIES!
FOSTERING THE NEXT GENERATION OF RESEARCHER IN HEALTH DISPARITIES! Translational Research at the Puerto Rico clinical and Translational Consortium. Defining Translational Research Series Objective. 1.
More informationJust Do It! Improving Cognition in FASD. Although FAS and associated disorders were first described in 1973 (Jones &
Just Do It! Improving Cognition in FASD Although FAS and associated disorders were first described in 1973 (Jones & Smith), only recently has attention been paid to finding effective methods for intervention
More informationNational Institutes of Health Open Grant Opportunities
Open Grant Opportunities Sponsor Name of Program Brief Description Opportunity ID National Institute of Arthritis and Musculoskeletal and Skin Disease 8 /7 /2018 Mechanistic Ancillary Studies to Ongoing
More informationBiomarkers of Neuroinflammation: A Workshop
Biomarkers of Neuroinflammation: A Workshop March 20 and 21, 2017 National Academy of Sciences Building 2101 Constitution Avenue, NW Washington, DC Background: Innate and adaptive immunity have become
More informationOpen Translational Science in Schizophrenia. Harvard Catalyst Workshop March 24, 2015
Open Translational Science in Schizophrenia Harvard Catalyst Workshop March 24, 2015 1 Fostering Use of the Janssen Clinical Trial Data The goal of this project is to foster collaborations around Janssen
More informationAssociation of American Cancer Institutes
Association of American Cancer Institutes Statement by the Association of American Cancer Institutes on Fiscal Year (FY) 2016 Appropriations for the Department of Health and Human Services Subcommittee
More informationOverview of the NIH. National Institutes of Health (NIH)
Overview of the National Institutes of Health (NIH) October 16, 2008 Craig Formby, Ph.D. Distinguished Graduate Research Professor Colleges of Arts & Sciences, Medicine, and Engineering Director, Office
More informationISSUE DATE: 2/10/2006
BULLETIN COMMONWEALTH OF PENNSYLVANIA Department of Public Welfare Department of Health NUMBER: OMHSAS-06-03 ISSUE DATE: 2/10/2006 EFFECTIVE DATE: Immediately SUBJECT: Co-Occurring Disorder Competency
More informationSUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS
SUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS 1 SUBSTANCE-EXPOSED INFANTS Refers to infants exposed to alcohol and or other substances ingested
More informationHealthy People A Resource for Promoting Health and Preventing Disease Throughout the Nation. Office of Disease Prevention and Health Promotion
Healthy People 2020 A Resource for Promoting Health and Preventing Disease Throughout the Nation Office of Disease Prevention and Health Promotion Healthy People Background and History What Is Healthy
More informationCommunity Health Improvement Plan
Community Health Improvement Plan Methodist University Hospital Methodist Le Bonheur Healthcare (MLH) is an integrated, not-for-profit healthcare delivery system based in Memphis, Tennessee, with 1,650
More information